Chirurgie beim lokalisierten nichtkleinzelligen Lungenkarzinom in den Frühstadien I und II

Abstract

BackgroundPrimary surgical resection is the treatment of choice for early stage non-small-cell lung cancer (NSCLC).ObjectiveDiscussion of the recent developments in thoracic surgical techniques for the treatment of early stage lung cancer and presentation of an outlook on possible innovations in the near future and how they may affect thoracic surgical oncology.ConclusionIn analogy to the development of systemic therapies, increasing personalization is taking place in modern oncologic surgery. Considering recent developments, the extent of resection can be tailored according to the tumor biology and functional status of the patient. In this context, lung-sparing anatomic segmentectomy enables the preservation of more healthy lung tissue, while providing equivalent oncologic value compared to conventional lobectomy and is thus becoming of increasing interest. In addition, well-established minimally invasive procedures, e.g., robot-assisted thoracic surgery, can now be more widely applied and could provide an opportunity to further improve outcomes.